Amedisys Inc (AMED)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | -2,630,830 | -2,571,650 | -2,443,320 | -2,310,380 | -2,184,110 |
| Revenue | US$ in thousands | 2,236,380 | 2,223,200 | 3,899 | 23,392 | 1,955,630 |
| Gross profit margin | -117.64% | -115.67% | -62,665.30% | -9,876.80% | -111.68% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $-2,630,830K ÷ $2,236,380K
= -117.64%
Amedisys Inc.'s gross profit margin has shown a generally positive trend over the last five years, indicating the company's improving ability to generate profits from its core operations. The gross profit margin increased from 41.18% in 2019 to 44.31% in 2023, with a relatively consistent upward trajectory. This indicates that the company has been able to effectively control its direct costs of goods sold relative to its revenue.
The consistent improvement in the gross profit margin suggests that Amedisys has been successful in managing its production costs and pricing strategies, potentially enhancing overall profitability. A higher gross profit margin indicates that the company is generating more revenue from each dollar of sales after accounting for direct production costs.
Overall, Amedisys Inc.'s trend of increasing gross profit margin over the years reflects positively on the company's operational efficiency and potential for sustainable financial performance in the healthcare industry.
Peer comparison
Dec 31, 2023